Histopathological substrate for chronic atrial fibrillation in humans
about
Right atrium thrombosis in nonvalvular permanent atrial fibrillationIon Channels in the HeartTriggers and anatomical substrates in the genesis and perpetuation of atrial fibrillationLeft Atrial Size and Function in a Canine Model of Chronic Atrial Fibrillation and Heart FailureRole of the autonomic nervous system in atrial fibrillation: pathophysiology and therapyObesity and atrial fibrillation.Spontaneous atrial fibrillation initiated by tyramine in canine atria with increased sympathetic nerve sproutingTelocytes accompanying cardiomyocyte in primary culture: two- and three-dimensional culture environmentCardiac telocytes: serial dynamic images in cell culture.Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythmAtrial fibrillation: mechanisms, therapeutics, and future directions.Anatomical basis of minimally invasive epicardial ablation of atrial fibrillation.Science Linking Pulmonary Veins and Atrial Fibrillation.Current controversies in determining the main mechanisms of atrial fibrillation.Myocardial Ischemia as a Genuine Cause Responsible for the Organization and "Fertilization" of Conflictogenic Atrial Fibrillation:New Conceptual Insights Into Arrhythmogenicity.Myocardial Telocytes: A New Player in Electric Circuitry of the Heart.Clinical utility of sympathetic blockade in cardiovascular disease management.A pilot study of circulating PPAR-γ receptor protein in elderly patients with atrial fibrillation.Association of intramural fat deposition in the interatrial septum with focal atrial tachyarrhythmias originating near the atrioventricular nodeClinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics.Neuro-atriomyodegenerative origin of atrial fibrillation and superimposed conventional risk factors: continued search to configure the genuine etiology of "eternal arrhythmia".Atrial Fibrillation Promotion in a Rat Model of Rheumatoid Arthritis.Current Understanding on Mechanisms Leading to Atrial Fibrillation.Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue.Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications.Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation.Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.Indexed Left Atrial Adipose Tissue Area Is Associated With Severity of Atrial Fibrillation and Atrial Fibrillation Recurrence Among Patients Undergoing Catheter Ablation.Atrial Fibrillation Mechanisms and Implications for Catheter Ablation
P2860
Q26827185-A3F181A9-C42D-4C21-96C7-5DE33860E7DBQ26829681-351295FC-215E-42C0-A75F-DC418E1830F4Q26858987-D84A8F8F-DE62-4598-BD06-ABE369FF75E9Q27330229-5C4E90FB-A22C-4E3E-B837-0AA096918C1BQ33706395-0BE8F333-7165-4011-B4E7-54E1EC10CB11Q34359362-46AC8082-8113-4E2E-88C4-2AA6C2A45B75Q35191509-B54ACB51-6CE2-4F3C-B5F5-48EB547D7371Q35216423-849C5D58-1D3A-43A5-865E-6253D627A4A0Q35216427-09A99CFD-F2DD-45C2-BEF7-9CEF00F7E216Q36287597-F909AE13-55D3-41E5-8CE8-EEA332F47554Q37590158-8A0DAD5E-C5ED-4AA9-BE90-2FB089F3ED32Q38056622-A9DA4637-B858-47C9-9C13-3B5429AE9CB2Q38719301-544B2506-9272-4F4A-AB0D-C6547DBCCD84Q38780259-C75C8429-678E-4574-812E-4E3952C4CA70Q38790508-511CADF3-AFFD-4F3B-A77A-F1EDD15E1C23Q38994844-74B8D4F0-E9CB-45EF-B6FB-8A217B23624EQ39177907-492F512A-FF70-41CC-86A9-386254B92027Q41955585-6B854F72-BB53-4FE0-A1D2-A8029AA15870Q42573919-0EAE1AB6-DA0D-4F25-8F8D-939CD9433C09Q46336435-6644F478-6C2F-4ED0-875A-31099D5E4613Q47127430-9857C21A-0759-47BE-B9C7-F76AE873BC50Q47263251-425D1DE7-D620-4A2C-B7C9-54F7175804BEQ50019560-E30C0C95-A850-41D5-A3B8-660782B704B6Q51190869-C9797DF5-2812-4864-A36E-0A79F4124C70Q52340243-379946E0-179C-4BCE-A7E6-41CFF50BA5AEQ53065630-7A2D3634-08CE-485C-8642-FFB5F9B18468Q54650363-2BBA9C96-65E1-402E-AE8F-A38DB3CFBB12Q55438771-3D0CDE2E-A43D-4402-A2B7-773628B7F4E6Q59136309-336206C4-3B02-4899-866E-8BD8DF750519
P2860
Histopathological substrate for chronic atrial fibrillation in humans
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Histopathological substrate for chronic atrial fibrillation in humans
@en
Histopathological substrate for chronic atrial fibrillation in humans.
@nl
type
label
Histopathological substrate for chronic atrial fibrillation in humans
@en
Histopathological substrate for chronic atrial fibrillation in humans.
@nl
prefLabel
Histopathological substrate for chronic atrial fibrillation in humans
@en
Histopathological substrate for chronic atrial fibrillation in humans.
@nl
P2093
P2860
P1433
P1476
Histopathological substrate for chronic atrial fibrillation in humans
@en
P2093
Bich Lien Nguyen
Lan S Chen
Michael C Fishbein
Peng-Sheng Chen
Saqib Masroor
P2860
P304
P356
10.1016/J.HRTHM.2009.01.010
P577
2009-01-16T00:00:00Z